SE7506293L - Farmaceutiska kompositioner for behandling av hyperkolesterolemi. - Google Patents

Farmaceutiska kompositioner for behandling av hyperkolesterolemi.

Info

Publication number
SE7506293L
SE7506293L SE7506293A SE7506293A SE7506293L SE 7506293 L SE7506293 L SE 7506293L SE 7506293 A SE7506293 A SE 7506293A SE 7506293 A SE7506293 A SE 7506293A SE 7506293 L SE7506293 L SE 7506293L
Authority
SE
Sweden
Prior art keywords
hypercolesterolemia
treatment
pharmaceutical compositions
pharmaceutical
compositions
Prior art date
Application number
SE7506293A
Other languages
English (en)
Inventor
A N Howard
Original Assignee
Bristol Myers Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bristol Myers Co filed Critical Bristol Myers Co
Publication of SE7506293L publication Critical patent/SE7506293L/sv

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
    • A61K31/215—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients

Landscapes

  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Epidemiology (AREA)
  • Inorganic Chemistry (AREA)
  • Emergency Medicine (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Steroid Compounds (AREA)
SE7506293A 1974-06-04 1975-06-02 Farmaceutiska kompositioner for behandling av hyperkolesterolemi. SE7506293L (sv)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB24794/74A GB1501096A (en) 1974-06-04 1974-06-04 Methods and pharmaceutical preparation for the treatment of hypercholesterolaemia

Publications (1)

Publication Number Publication Date
SE7506293L true SE7506293L (sv) 1975-12-05

Family

ID=10217337

Family Applications (1)

Application Number Title Priority Date Filing Date
SE7506293A SE7506293L (sv) 1974-06-04 1975-06-02 Farmaceutiska kompositioner for behandling av hyperkolesterolemi.

Country Status (17)

Country Link
US (1) US4041153A (sv)
JP (1) JPS5112934A (sv)
BE (1) BE829859A (sv)
CA (1) CA1038291A (sv)
DE (1) DE2524882A1 (sv)
DK (1) DK248975A (sv)
FI (1) FI751630A (sv)
FR (1) FR2273517A1 (sv)
GB (1) GB1501096A (sv)
IE (1) IE41074B1 (sv)
IL (1) IL47378A (sv)
NL (1) NL7506609A (sv)
NO (1) NO751973L (sv)
NZ (1) NZ177627A (sv)
PH (1) PH13199A (sv)
SE (1) SE7506293L (sv)
ZA (1) ZA753615B (sv)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4180566A (en) * 1978-05-15 1979-12-25 W. R. Grace & Co. Silica gel method of reducing blood lipid concentration
FR2574295B1 (fr) * 1984-12-07 1988-02-26 Rech Etu Therapeutiques Medicaments a base de gluconate de zinc utiles pour le traitement des hyperprolactinemies
US4818539A (en) * 1985-02-05 1989-04-04 Warner-Lambert Company Ingestible aggregate and delivery system prepared therefrom
US4851392A (en) * 1985-02-05 1989-07-25 Warner-Lambert Company Ingestible aggregate and delivery system prepared therefrom
US4843098A (en) * 1985-02-05 1989-06-27 Warner-Lambert Company Ingestible aggregate and delivery system prepared therefrom
US4747881A (en) * 1985-02-05 1988-05-31 Warner-Lambert Company Ingestible aggregate and delivery system prepared therefrom
US4790991A (en) * 1985-02-05 1988-12-13 Warner-Lambert Company Ingestible aggregate and delivery system prepared therefrom
US4759923A (en) * 1987-06-25 1988-07-26 Hercules Incorporated Process for lowering serum cholesterol using poly(diallylmethylamine) derivatives
US5025037A (en) * 1989-11-03 1991-06-18 Livingston William H Uses for the oral use of oak poison preventative in the treatment of: feline leukemia, increased wool production in sheep, and reduction of shipping fever in stressed animals
US20050106267A1 (en) * 2003-10-20 2005-05-19 Framework Therapeutics, Llc Zeolite molecular sieves for the removal of toxins

Also Published As

Publication number Publication date
GB1501096A (en) 1978-02-15
BE829859A (fr) 1975-12-04
PH13199A (en) 1980-01-28
JPS5112934A (sv) 1976-01-31
NL7506609A (nl) 1975-12-08
CA1038291A (en) 1978-09-12
DE2524882A1 (de) 1975-12-18
IL47378A (en) 1978-06-15
US4041153A (en) 1977-08-09
DK248975A (da) 1975-12-05
FR2273517B1 (sv) 1978-10-06
NZ177627A (en) 1978-04-03
IE41074B1 (en) 1979-10-10
IL47378A0 (en) 1975-08-31
IE41074L (en) 1975-12-04
FI751630A (sv) 1975-12-05
NO751973L (sv) 1975-12-05
FR2273517A1 (fr) 1976-01-02
AU8159375A (en) 1976-12-02
ZA753615B (en) 1977-02-23

Similar Documents

Publication Publication Date Title
SE7505040L (sv) Forfarande for framstellning av n-fosfonometylglycin.
NO157933C (no) Analogifremgangsmaate for fremstilling av terapeutisk virksomme cefemforbindelser.
DOP1980002892A (es) Composicion farmaceutica
SE7507896L (sv) Inplanterbar anordning for forfarande for tillverkning av densamma.
NO143460C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive benzomorfaner.
NO141800C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive benzomorfaner.
SE412401B (sv) Forfarande for framstellning av polyvinylpyrroliden-jod
SE7506293L (sv) Farmaceutiska kompositioner for behandling av hyperkolesterolemi.
SE7506731L (sv) Komposition for behandling av akne.
OA04641A (fr) Prcédé de préparation de 3-fluorocéphalosporines.
NO145383C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive substituerte indoler.
SE428015B (sv) Forfarande for framstellning av 3.4-dihydrokarbostyrilderivat
NO146142C (no) Fremgangsmaate for behandling av trefils
SE7504923L (sv) Forfarande for framstellning av tetrazoler.
SE404926B (sv) Analogiforfarande for framstellning av 3-piperazin-isokinoliner
SE7512422L (sv) Forfarande for framstellning av 1,2,3,4-tetrahydroisokinoliner
NO139684C (no) Fremgangsmaate for fremstilling av n,n-diallyldikloracetamid
NO146714C (no) Fremgangsmaate for fremstilling av saapestykker.
SE7507482L (sv) Forfarande for framstellning av substituerade l-sulfonylbensimidazoler.
FR2285871A1 (fr) Compositions pharmaceutiques
NO143626C (no) Fremgangsmaate til fremstilling av 2-alkyl-5-nitroimidazolderivater.
SE7505136L (sv) Forfarande for framstellning av bis (2-pyridyl-l-oxid)-disulfid.
SE7508844L (sv) Forfarande for framstellning av cefalosporiner.
NO149427C (no) Fremgangsmaate for fremstilling av fenyl- henholdsvis naftyl-uretaner.
SE7506763L (sv) Forfarande for framstellning av alfa-diol-gamma-dioxoforeningar.